LCBiot-GILGFVFTL-OH

Ref. 3D-PP49159

Informations sur le produit

• Nom: LCBiot-GILGFVFTL-OH

Description

Peptide LCBiot-GILGFVFTL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-GILGFVFTL-OH include the following: Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes XH He, LH Xu, Y Liu - World Journal of Gastroenterology: WJG, 2005 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615439/ Combinatorial HLA-peptide bead libraries for high throughput identification of CD8+ T cell specificity X Pan, LC Huang, T Dong , Y Peng, V Cerundolo - Journal of , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175913003608 Sequence dependent conformational motion of a peptide in the HLA-A2 binding groove WS Meng , TK Gallaher - Protein and Peptide , 1996 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=4hzqbXzny7cC&oi=fnd&pg=PA51&dq=(%22GILGFVFTL%22+OR+%22LCBiot-GILGFVFTL-OH%22)+AND+peptide&ots=apCmiTqwRJ&sig=Pibv3lOsxavOdnlGKkapmw_N1e8 Rational design of peptide-based tumor vaccines WS Meng , LH Butterfield - Pharmaceutical research, 2002 - Springerhttps://link.springer.com/article/10.1023/A:1016497818471 Exploiting the Peptide-MHC Water Interface in the Computer-Aided Design of Non-Natural Peptides that Bind to the Class I MHC Molecule HLA-A2 WS Meng , HH Bui, IS Haworth - Molecular Simulation, 2000 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/08927020008022372 Development of Pro-Peptide Immunotherapy for Breast Cancer W Wei-Zan, WAYNE STATE UNIV DETROIT MI - 2000., 2000 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA385378 CHARACTERISATION OF MHC-PEPTIDE BINDING SPECIFICITIES BY STRUCTURAL STUDIES TOH XINYU - 2012 - core.ac.ukhttps://core.ac.uk/download/pdf/48655789.pdf Functional characterization of CTL against gp100 altered peptide ligands SO Dionne, MH Smith, FM Marincola - Cancer Immunology , 2003 - Springerhttps://link.springer.com/article/10.1007/s00262-002-0358-3 Antigen presentation of a modified tumor-derived peptide by tumor infiltrating lymphocytes SO Dionne, MH Smith, FM Marincola, DF Lake - Cellular immunology, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874901918933 Towards chemically altered peptide ligands as T cell-targeted influenza vaccines SKR Huber, JJ Luimstra - for peptide , 2015 - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2919352/download#page=106 Chemical modification of influenza CD8+ T-cell epitopes enhances their immunogenicity regardless of immunodominance SK Rosendahl Huber, JJ Luimstra, J van Beek - PloS one, 2016 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156462 Peptide super-agonist enhances T-cell responses to melanoma SAE Galloway, G Dolton , M Attaf, A Wall - Frontiers in , 2019 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2019.00319/full Immune responses against conserved influenza epitopes: lessons for peptide S Rosendahl Huber - Scand J Immunol, 1997 - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2919359/download Synthesis and biological activity of the prodrug of class I major histocompatibility peptide GILGFVFTL activated by beta-glucuronidase S Rawale, LM Hrihorczuk, Wei - Journal of medicinal , 2002 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jm010352w Altered peptide ligands revisited: Vaccine design through chemically modified HLA-A2-restricted T cell epitopes R Hoppes, R Oostvogels , JJ Luimstra - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/193/10/4803/97379 Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination Q Chen , H Jackson, M Shackleton , P Parente - Cancer Immunity, 2005 - AACRhttps://aacrjournals.org/cancerimmun/article-abstract/5/1/5/471995 Whole inactvated influenza virus as an adjuvant for influenza peptide antigens PC Soema, SKR Huber, GJ Willems, JP Amorij - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2895100/download Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8+ T Cell Epitopes PC Soema, SK Rosendahl Huber, GJ Willems - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.00525/full Formulation of influenza T cell peptides: in search of a universal influenza vaccine P Soema - 2015 - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2895105/download Prediction and preliminary screening of HLA-A* 0201-restricted epitope peptides of human GPC 3 P Hu, Z Wei, R Li, D Wu, Z Meng - International Journal of , 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/iji.12260 Competition among peptides in melanoma vaccines for binding to MHC molecules LW Thompson, CF Garbee, S Hibbitts - Journal of , 2004 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2004/11000/competition_among_peptides_in_melanoma_vaccines.2.aspx Real time detection of peptide-MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stability KM Miles, JJ Miles , F Madura, AK Sewell , DK Cole - Molecular immunology, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589010006073 Immunodominant influenza epitope GILGFVFTL engage common and divergent TCRs when presented as a 9-mer or a 15-mer peptide K Bhojak, V Kode, CM Miriam, K Lee, A Ramesh - bioRxiv, 2022 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2022.07.11.499638.abstract Peptide mimic for influenza vaccination using nonnatural combinatorial chemistry JJ Miles , MP Tan, G Dolton - The Journal of , 2018 - Am Soc Clin Investighttps://www.jci.org/articles/view/91512 Machine Learning Prediction of TCR-Epitope Binding J Faust, YS Song - 2022 - eecs.berkeley.eduhttps://www2.eecs.berkeley.edu/Pubs/TechRpts/2022/EECS-2022-216.pdf Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies J Bae, JA Martinson, HG Klingemann - Clinical cancer research, 2005 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/11/4/1629/188888 Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain G Xiaoling, L Ying , L Jing, L Huifang, Z Xia - Cancer Immunology , 2005 - Springerhttps://link.springer.com/article/10.1007/s00262-005-0696-z EWS-FLI-1-targeted cytotoxic T-cell killing of multiple tumor types belonging to the Ewing sarcoma family of tumors CH Evans, F Liu, RM Porter , RP O'Sullivan - Clinical Cancer , 2012 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/18/19/5341/283885 CTL recognition of a novel HLA-A* 0201-binding peptide derived from glioblastoma multiforme tumor cells CE Myers, P Hanavan, K Antwi, D Mahadevan - Cancer Immunology , 2011 - Springerhttps://link.springer.com/article/10.1007/s00262-011-1032-4 Structural and functional characterization of peptide-beta2m fused HLA-A2/MART127-35 complexes C Shen, CC Chang, J Zhang, W Guo, L Xia - Biochemical and , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X06001999 Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A* 0201-binding peptides from the Melan-A/MART A van Elsas , SH van der Burg - European journal of , 1996 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830260803 Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A* 0201 A Van Elsas , HW Nijman - journal of cancer, 1995 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.2910610319 Immunological interactions of virus peptides at the antigen presenting MHC I proteins A Rashidian - Bioinformatics, 2018 - utupub.fihttps://www.utupub.fi/bitstream/handle/10024/146525/Rashidian_Azam_Thesis.pdf?sequence=1 Use of Immobilized HLA-A2:Ig Dimeric Proteins to Determine the Level of Epitope-Specific, HLA-Restricted CD8+ T-Cell Response A Horowitz , X Li, MA Poles - Scandinavian journal of , 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-3083.2009.02317.x Identification of B cell epitopes reactive to human papillomavirus type-16L1-derived peptides A Fukui, S Matsueda , K Kawano, N Tsuda, N Komatsu - Virology journal, 2012 - Springerhttps://link.springer.com/article/10.1186/1743-422X-9-199

• Marque: Biosynth